Healthcare and Medical
Healthcare and Medical
home | healthcare and medical | company profile
Regeneron Pharmaceuticals Inc - Premium Company Profile (Datamonitor)
- Market: Healthcare and Medical
- Published Date: 24/12/2007
- Report Title: Regeneron Pharmaceuticals Inc - Premium Company Profile
- Table of Contents: View Table of Contents
- Report Type: Company Profile
- Country: Global
- Number of Pages: 51
Introduction
Regeneron Pharmaceuticals is a biopharmaceutical company mainly focused on the development and commercialization of products for oncology, age-related macular degeneration (AMD), and autoimmune diseases. The company is developing its drugs using its Trap technology, which is designed to block key cytokine targets in order to treat disease.
Scope
Contains corporate strategy, value chain presence and SWOT Analysis Provides detailed business description, segment analysis, 5-year financial trends, key products and key competitors Includes information on suppliers/ partners, shareholding structure and key employees with biographies
Highlights
Regeneron Pharmaceuticals discovers, develops, and intends to commercialize therapeutic medicines for the treatment of serious medical conditions. Regeneron has therapeutic candidates for the potential treatment of cancer, eye diseases, and inflammatory diseases and has preclinical programs in other diseases and disorders.
The company derives all of its revenues from contract manufacturing, research and development payments from collaborators and licensing of products. Its total revenues increased at a CAGR of 30% during 2002-2006, from $22 million to $63 million.
Regeneron Pharmaceuticals's total revenues are forecast to increase at a CAGR of 57% from $51 million to $308 million during 2006-2010, representing an absolute growth of +$257 million. The increase in contract and collaborative revenues is due to the advancement of product candidates under collaborations with Bayer Healthcare and Sanofi-Aventis.
Reasons to Purchase
Access all the important information and analysis on the company in a single report Understand company's strengths, weaknesses, opportunities and threats along with business strategy and value chain Gain access to company's adjusted five year financial data along with key ratios and market capitalization
Scope
Highlights
Reasons to Purchase
Purchase Information
There are various ways to purchase products from our site. Select the report title(s) you are interested in, and add it to your basket. At the Checkout page, you will be requested to submit your details. You will then have the option to pay via various methods: Debit Card ; Credit Card ; Purchase via Invoice (inc. Purchase Order no. if required) and Paypal. Companiesandmarkets.com accepts Visa, MasterCard, Diners, American Express, JCB and all the major credit cards. Companiesandmarkets.com uses RBSWorldpay.
Once you have purchased your report(s), you will receive a confirmation email. You will then either be able to download your report(s) immediately from your Customer Area in PDF format, or the report(s) will be emailed to you directly, depending on the agreement we have with the publisher. Orders that are deliverable via email which are taken outside of working hours will be delivered next business day.
Please note, if you purchase by invoice, you will receive your report(s) once payment has been received. If you have any questions about how to order, please Contact Us.
